Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population?
- PMID: 15520856
- PMCID: PMC524241
- DOI: 10.1172/JCI23466
Do DNA sequence variants in ABCA1 contribute to HDL cholesterol levels in the general population?
Abstract
HDL has a key role in reverse cholesterol transport, mobilizing cholesterol from the peripheral tissues to liver. In this process, the ABC transporter A1 (ABCA1) protein controls the efflux of intracellular cholesterol to apoAI, the major apolipoprotein of HDL. Since ABCA1 mutations were discovered to cause Tangier disease, a rare recessive HDL deficiency, it has been speculated that sequence variants in ABCA1 might also contribute to variations in plasma HDL cholesterol levels in the general population. A new study provides genetic evidence supporting this hypothesis.
Figures
Comment on
-
Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population.J Clin Invest. 2004 Nov;114(9):1343-53. doi: 10.1172/JCI20361. J Clin Invest. 2004. PMID: 15520867 Free PMC article.
References
-
- Breslow, J.L. 1995. Familial disorders of high density lipoprotein metabolism. In The metabolic and molecular bases of inherited disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill. New York, New York, USA. 2031–2052.
-
- Bodzioch M, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 1999;22:347–351. - PubMed
-
- Brooks-Wilson A, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 1999;22:336–345. - PubMed
-
- Rust S, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 1999;22:352–355. - PubMed
